Presentation is loading. Please wait.

Presentation is loading. Please wait.

Basic Immunology of the Mouse (and Human) Nicholas P. Restifo, MD October 19, 2015.

Similar presentations


Presentation on theme: "Basic Immunology of the Mouse (and Human) Nicholas P. Restifo, MD October 19, 2015."— Presentation transcript:

1 Basic Immunology of the Mouse (and Human) Nicholas P. Restifo, MD October 19, 2015

2 Life started on earth about 3.5 billion years ago: mammals are a ‘recent’ development

3 Meet your great, great ~50M -grandfather

4 Figure 8-1

5 Schematic Diagram Of The CD8 and CD4 Coreceptors

6 How T cell receptors, peptides and MHC molecules fit together

7 Schematic map of the human and mouse MHC superloci

8 Nomenclature of major histocompatibility complex (MHC) Mouse Human KbKb Location (locus) Strain designation

9 Naming MHC molecules is easy All MHC molecules in this C57BL/6 mouse are called b All MHC molecules in this BALB/c mouse are called d

10 CD8 + T cell CD4 + T cell Tumor cell Antigen Presenting Cell Tumor Antigen What do T cells “see?”

11 T-cell recognition of antigens is MHC restricted

12 Figure 3-22

13 Pathways of antigen processing and presentation

14 TCR-peptide-MHC Crystal Structure

15 Figure 4-11 The germline organization of the human T-cell receptor  and β loci

16 The numbers of human T-cell receptor gene segments and the sources of T-cell receptor diversity compared with those of immunoglobulins

17 Adoptive cell transfer (ACT) in mouse and man Tumor is established time Ablate host immune system Adoptively transfer T cells Add vaccine and cytokine support Tumor regression?

18 ‘TIL’-based adoptive immunotherapy t t T Infusion of tumour- specific T cells into patient T Fragmentation of tumour mass t Activation and selection of T cells T cell growth factors (such as IL-2) T cell growth factors (such as IL-2) Add T cell growth factors (such as IL-2) t Chemotherapy +/- irradiation Restifo, NP, et al, Nat Rev Immunol, April, 2012 Expansion of tumour- specific T cell populations T

19

20

21 Survival of patients with metastatic melanoma treated with adoptive cell transfer therapy and IL-2 93 patients treated with adoptive transfer of TIL: 9/13/2000-8/30/2009 Dudley, J Clin Oncol, 2008; Rosenberg, Clin Cancer Res, 2011. Median follow-up time 79 months (n=93)

22

23


Download ppt "Basic Immunology of the Mouse (and Human) Nicholas P. Restifo, MD October 19, 2015."

Similar presentations


Ads by Google